Activity Catalog
Date
Event
 
Registration
Saturday-04/25/15
8:00 AM - 3:30 PM
 
Maintenance of Certification in Anesthesia (MOCA) Simulation Education Course
MOCA Simulation
Objective: After participating in this CME activity, participants should be able to: 1.Manage a patient undergoing anesthesia who experiences a hemodynamic critical event. 2.Manage a patient undergoing anesthesia who experiences a respiratory critical event. 3.Describe and discuss optimal teamwork, leadership and communication skills required during crisis management. 4.Perform an effective handover.
Shock Trauma Learning Center
Course Director: Wendy Bernstein, MD, MBA
Coordinator: Althea Pusateri/Wanda Belton
Target Audience: Anesthesiologists - MD & DO
Credits Offered: AMA PRA Category 1 Credits™ - 7.00
Registration is closed for this event. Please register for one of the future MOCA dates, May, June, September, October 2015. Thank you.
Tuesday-04/28/15
8:00 AM - 5:00 PM
 
Portfolio: Ambulatory Electronic Medical Record Training
UMMC
Course Director: Mark Kelemen, MD
Coordinator: Tiffany Ingram
Target Audience: All Ambulatory Providers
Credits Offered: AMA PRA Category 1 Credits™ - 8.00; Attendance - 8.00
Date
Event
 
Registration
Thursday-05/7/15
  - thru -
 Friday-05/8/15
8:00 AM - 5:00 PM
 
2014 - 2015 Introduction to Emergency Ultrasound
Objective: At the conclusion of this activity, participants will be able to: 1. List the six core areas of emergency ultrasound 2. Demonstrate skills in image acquisition and interpretation 3. Discuss the incorporation of ultrasound into the practice of emergency medicine
UMMC
Course Director: Brian Euerle, MD
Coordinator: Angela Taylor
Target Audience: Emergency Medicine Physicians
Credits Offered: AMA PRA Category 1 Credits™ - 16.00; Attendance - 16.00
Saturday-05/9/15
8:00 AM - 3:30 PM
 
Maintenance of Certification in Anesthesia (MOCA) Simulation Education Course
MOCA Simulation
Objective: After participating in this CME activity, participants should be able to: 1.Manage a patient undergoing anesthesia who experiences a hemodynamic critical event. 2.Manage a patient undergoing anesthesia who experiences a respiratory critical event. 3.Describe and discuss optimal teamwork, leadership and communication skills required during crisis management. 4.Perform an effective handover.
Shock Trauma Learning Center
Course Director: Wendy Bernstein, MD, MBA
Coordinator: Althea Pusateri/Wanda Belton
Target Audience: Anesthesiologists - MD & DO
Credits Offered: AMA PRA Category 1 Credits™ - 7.00
Monday-05/11/15
10:00 AM - 11:00 AM
 
2014 CERSI Series
Objective: At the conclusion of this activity, participants will be able to: 1. Discuss new regulatory science advances related to pre-clinical assessment of safety and efficacy, emerging technologies, and assessing diverse data sets through information sciences to improve health outcomes 2. Explain regulatory science advances pertinent to the review of drug or device applications for safety and efficacy and post-approval responsibilities 3. Identify tools, standards or approaches to assess the safety, efficacy, quality and performance of FDA-regulated products 4. Describe the role of regulatory science advances pertinent to regulatory decision making
FDA
Course Director: Curt I. Civin, MD
Coordinator: Ann Anonsen
Target Audience: CERSI Participants and FDA Only
Credits Offered: AMA PRA Category 1 Credits™ - 1.00; Attendance - 1.00
Friday-05/15/15
10:00 AM - 11:00 AM
 
2014 CERSI Series
Objective: At the conclusion of this activity, participants will be able to: 1. Discuss new regulatory science advances related to pre-clinical assessment of safety and efficacy, emerging technologies, and assessing diverse data sets through information sciences to improve health outcomes 2. Explain regulatory science advances pertinent to the review of drug or device applications for safety and efficacy and post-approval responsibilities 3. Identify tools, standards or approaches to assess the safety, efficacy, quality and performance of FDA-regulated products 4. Describe the role of regulatory science advances pertinent to regulatory decision making
FDA
Course Director: Curt I. Civin, MD
Coordinator: Ann Anonsen
Target Audience: CERSI Participants and FDA Only
Credits Offered: AMA PRA Category 1 Credits™ - 1.00; Attendance - 1.00
Tuesday-05/19/15
5:30 PM - 7:30 PM
 
IHV Case Conference Series 2015
New12102
Objective: At the conclusion of this activity, participants will be able to: 1. Treat and manage difficult cases in HIV 2. Manage a complex caseload 3. Define co-morbidities 4. Treat HCV and HIV 5. Describe the treatment cascade and how to achieve better outcomes along the continuum
725 West Lombard St., 6th Floor
Course Director: Bruce Gilliam, MD
Coordinator: Danielle Confer
Target Audience: Physicians, Resident/Fellows, Nurses, Physicians Assistant
Credits Offered: AMA PRA Category 1 Credits™ - 1.50; Attendance - 1.50
Date
Event
 
Registration
Tuesday-06/9/15
12:30 PM - 5:00 PM
 
CHAMP Training 2015
Champ Training
Objective: At the conclusion of this activity, participants will be able to: 1. Assess alleged child abuse and neglect 2. Describe and define issues such as sexual assault laws or HIV post-exposure prophylaxis 3. Competently perform their consultation role regarding maltreated children
Course Director: Howard Dubowitz, MD
Coordinator: Emily Redding
Target Audience: Pediatricians, ED Doctors, Nurses
Credits Offered: AMA PRA Category 1 Credits™ - 4.00; Attendance - 4.00
Friday-06/12/15
10:00 AM - 11:00 AM
 
2014 CERSI Series
Objective: At the conclusion of this activity, participants will be able to: 1. Discuss new regulatory science advances related to pre-clinical assessment of safety and efficacy, emerging technologies, and assessing diverse data sets through information sciences to improve health outcomes 2. Explain regulatory science advances pertinent to the review of drug or device applications for safety and efficacy and post-approval responsibilities 3. Identify tools, standards or approaches to assess the safety, efficacy, quality and performance of FDA-regulated products 4. Describe the role of regulatory science advances pertinent to regulatory decision making
FDA
Course Director: Curt I. Civin, MD
Coordinator: Ann Anonsen
Target Audience: CERSI Participants and FDA Only
Credits Offered: AMA PRA Category 1 Credits™ - 1.00; Attendance - 1.00
Monday-06/15/15
12:30 PM - 4:30 PM
 
Critical Procedures Course
New12108
Objective: The objectives for each procedure include learning the indications, contraindications, equipment, technique, complications, sites, post procedure follow up and pearls needed to perform the procedures competently. Ultimately these emergency medicine procedures will be practiced in a controlled setting on human cadavers. The list of procedures covered in the curriculum is as follows: 1. Lateral canthotomy 2. Facial nerve blocks 3. Endotracheal intubation 4. Retrograde intubation 5. Cricothyrotomy 6. Central venous access 7. Tube thoracostomy 8. Emergency thoracotomy 9. Pericardiocetesis 10. Arthrocentesis of wrist 11. Arthrocentesis of knee
Anatomy Lab
Course Director: Siamak Moayedi, MD
Coordinator: Angela Taylor
Target Audience: Emergency Medicine, Critical Care
Credits Offered: AMA PRA Category 1 Credits™ - 4.00; Attendance - 4.00
Wednesday-06/17/15
5:30 PM - 7:30 PM
 
IHV Case Conference Series 2015
New12103
Objective: At the conclusion of this activity, participants will be able to: 1. Treat and manage difficult cases in HIV 2. Manage a complex caseload 3. Define co-morbidities 4. Treat HCV and HIV 5. Describe the treatment cascade and how to achieve better outcomes along the continuum
725 West Lombard St., 6th Floor
Course Director: Bruce Gilliam, MD
Coordinator: Danielle Confer
Target Audience: Physicians, Resident/Fellows, Nurses, Physicians Assistant
Credits Offered: AMA PRA Category 1 Credits™ - 1.50; Attendance - 1.50
Saturday-06/27/15
8:00 AM - 3:30 PM
 
Maintenance of Certification in Anesthesia (MOCA) Simulation Education Course
MOCA Simulation
Objective: After participating in this CME activity, participants should be able to: 1.Manage a patient undergoing anesthesia who experiences a hemodynamic critical event. 2.Manage a patient undergoing anesthesia who experiences a respiratory critical event. 3.Describe and discuss optimal teamwork, leadership and communication skills required during crisis management. 4.Perform an effective handover.
Shock Trauma Learning Center
Course Director: Wendy Bernstein, MD, MBA
Coordinator: Althea Pusateri/Wanda Belton
Target Audience: Anesthesiologists - MD & DO
Credits Offered: AMA PRA Category 1 Credits™ - 7.00
Date
Event
 
Registration
Friday-07/10/15
10:00 AM - 11:00 AM
 
2014 CERSI Series
Objective: At the conclusion of this activity, participants will be able to: 1. Discuss new regulatory science advances related to pre-clinical assessment of safety and efficacy, emerging technologies, and assessing diverse data sets through information sciences to improve health outcomes 2. Explain regulatory science advances pertinent to the review of drug or device applications for safety and efficacy and post-approval responsibilities 3. Identify tools, standards or approaches to assess the safety, efficacy, quality and performance of FDA-regulated products 4. Describe the role of regulatory science advances pertinent to regulatory decision making
FDA
Course Director: Curt I. Civin, MD
Coordinator: Ann Anonsen
Target Audience: CERSI Participants and FDA Only
Credits Offered: AMA PRA Category 1 Credits™ - 1.00; Attendance - 1.00
Date
Event
 
Registration
Friday-08/14/15
10:00 AM - 11:00 AM
 
2014 CERSI Series
Objective: At the conclusion of this activity, participants will be able to: 1. Discuss new regulatory science advances related to pre-clinical assessment of safety and efficacy, emerging technologies, and assessing diverse data sets through information sciences to improve health outcomes 2. Explain regulatory science advances pertinent to the review of drug or device applications for safety and efficacy and post-approval responsibilities 3. Identify tools, standards or approaches to assess the safety, efficacy, quality and performance of FDA-regulated products 4. Describe the role of regulatory science advances pertinent to regulatory decision making
FDA
Course Director: Curt I. Civin, MD
Coordinator: Ann Anonsen
Target Audience: CERSI Participants and FDA Only
Credits Offered: AMA PRA Category 1 Credits™ - 1.00; Attendance - 1.00
Thursday-08/20/15
  - thru -
 Saturday-08/22/15
 
Advances in Vascular Surgery and Endovascular Therapy
Advances in Vascular Surgery
Objective: At the conclusion of this activity, participants will be able to: Describe new data/literature in the field of vascular surgery. Describe new techniques in the field of vascular surgery. Identify changes in their practice patterns to conform to new advances in vascular surgery.
Coordinator: Althea Pusateri/Tameka Dorsey
Target Audience:
Credits Offered:
This activity has been approved for AMA PRA Category 1 Credit TM
Date
Event
 
Registration
Friday-09/11/15
10:00 AM - 11:00 AM
 
2014 CERSI Series
Objective: At the conclusion of this activity, participants will be able to: 1. Discuss new regulatory science advances related to pre-clinical assessment of safety and efficacy, emerging technologies, and assessing diverse data sets through information sciences to improve health outcomes 2. Explain regulatory science advances pertinent to the review of drug or device applications for safety and efficacy and post-approval responsibilities 3. Identify tools, standards or approaches to assess the safety, efficacy, quality and performance of FDA-regulated products 4. Describe the role of regulatory science advances pertinent to regulatory decision making
FDA
Course Director: Curt I. Civin, MD
Coordinator: Ann Anonsen
Target Audience: CERSI Participants and FDA Only
Credits Offered: AMA PRA Category 1 Credits™ - 1.00; Attendance - 1.00
Monday-09/14/15
12:30 PM - 4:30 PM
 
Critical Procedures Course
New12109
Objective: The objectives for each procedure include learning the indications, contraindications, equipment, technique, complications, sites, post procedure follow up and pearls needed to perform the procedures competently. Ultimately these emergency medicine procedures will be practiced in a controlled setting on human cadavers. The list of procedures covered in the curriculum is as follows: 1. Lateral canthotomy 2. Facial nerve blocks 3. Endotracheal intubation 4. Retrograde intubation 5. Cricothyrotomy 6. Central venous access 7. Tube thoracostomy 8. Emergency thoracotomy 9. Pericardiocetesis 10. Arthrocentesis of wrist 11. Arthrocentesis of knee
Anatomy Lab
Course Director: Siamak Moayedi, MD
Coordinator: Angela Taylor
Target Audience: Emergency Medicine, Critical Care
Credits Offered: AMA PRA Category 1 Credits™ - 4.00; Attendance - 4.00
Saturday-09/19/15
8:00 AM - 3:30 PM
 
Maintenance of Certification in Anesthesia (MOCA) Simulation Education Course
Skills Training
Objective: After participating in this CME activity, participants should be able to: 1.Manage a patient undergoing anesthesia who experiences a hemodynamic critical event. 2.Manage a patient undergoing anesthesia who experiences a respiratory critical event. 3.Describe and discuss optimal teamwork, leadership and communication skills required during crisis management. 4.Perform an effective handover.
New12118
Shock Trauma Learning Center
Course Director: Wendy Bernstein, MD, MBA
Coordinator: Wanda Belton/Althea Pusateri
Target Audience: Anesthesiologists MD, DO
Credits Offered: AMA PRA Category 1 Credits™ - 7.00; Attendance - 7.00
Tuesday-09/22/15
5:30 PM - 7:30 PM
 
IHV Case Conference Series 2015
New12104
Objective: At the conclusion of this activity, participants will be able to: 1. Treat and manage difficult cases in HIV 2. Manage a complex caseload 3. Define co-morbidities 4. Treat HCV and HIV 5. Describe the treatment cascade and how to achieve better outcomes along the continuum
725 West Lombard St., 6th Floor
Course Director: Bruce Gilliam, MD
Coordinator: Danielle Confer
Target Audience: Physicians, Resident/Fellows, Nurses, Physicians Assistant
Credits Offered: AMA PRA Category 1 Credits™ - 1.50; Attendance - 1.50
Date
Event
 
Registration
Thursday-10/8/15
12:30 PM - 5:00 PM
 
CHAMP Training 2015
Champ Training
Objective: At the conclusion of this activity, participants will be able to: 1. Assess alleged child abuse and neglect 2. Describe and define issues such as sexual assault laws or HIV post-exposure prophylaxis 3. Competently perform their consultation role regarding maltreated children
Course Director: Howard Dubowitz, MD
Coordinator: Emily Redding
Target Audience: Pediatricians, ED Doctors, Nurses
Credits Offered: AMA PRA Category 1 Credits™ - 4.00; Attendance - 4.00
Friday-10/9/15
10:00 AM - 11:00 AM
 
2014 CERSI Series
Objective: At the conclusion of this activity, participants will be able to: 1. Discuss new regulatory science advances related to pre-clinical assessment of safety and efficacy, emerging technologies, and assessing diverse data sets through information sciences to improve health outcomes 2. Explain regulatory science advances pertinent to the review of drug or device applications for safety and efficacy and post-approval responsibilities 3. Identify tools, standards or approaches to assess the safety, efficacy, quality and performance of FDA-regulated products 4. Describe the role of regulatory science advances pertinent to regulatory decision making
FDA
Course Director: Curt I. Civin, MD
Coordinator: Ann Anonsen
Target Audience: CERSI Participants and FDA Only
Credits Offered: AMA PRA Category 1 Credits™ - 1.00; Attendance - 1.00
Friday-10/16/15
7:30 AM - 5:30 PM
 
Leading Edge Echocardiography and Interventional Procedures for Acute Care and Trauma
Objective: At the conclusion of this educational activity, participants should be able to: Explain basic principles of ultrasound and instrumentation. Correlate cardiac and vascular gross pathology with echocardiographic images. Establish solid ultrasound imaging standards, emphasizing fundamental scanning techniques and guidelines. Apply a systematic approach in performing the FREE, FAST and vascular imaging. Analyze and interpret ultrasound derived data from imaging and calculations. Define current treatment options for the management of bedside patients in acute, critical and trauma settings using ultrasound guidance. Increase competence in performing bedside ultrasound exams to answer critical decision-making questions that directly impact upon patient care and immediate patient management and outcome. Identify and achieve higher levels of competence. Operate ultrasound technology, including electronic imaging and electronic reports.
MASTRI Center - Gudelsky 7, S7B03
Course Director: Sarah Murthi, MD
Coordinator: Mary Ferguson/Althea Pusateri
Target Audience: Physicians in Critical Care, Trauma, Emergency Medicine, Trauma Surgeons, Residents, PA, Fellows, NP, RN
Credits Offered: AMA PRA Category 1 Credits™ - 8.25; Attendance - 8.25
Saturday-10/17/15
8:00 AM - 3:30 PM
 
Maintenance of Anesthesiology Certification in Anesthesia (MOCA) Simulation Education Course
Shock Trauma Learning Center
Course Director: Wendy Bernstein, MD, MBA
Coordinator: Wanda Belton/Althea Pustateri
Target Audience: Anesthesiologists MD, DO
Credits Offered: AMA PRA Category 1 Credits™ - 7.00; Attendance - 7.00
Wednesday-10/21/15
5:30 PM - 7:30 PM
 
IHV Case Conference Series 2015
New12105
Objective: At the conclusion of this activity, participants will be able to: 1. Treat and manage difficult cases in HIV 2. Manage a complex caseload 3. Define co-morbidities 4. Treat HCV and HIV 5. Describe the treatment cascade and how to achieve better outcomes along the continuum
725 West Lombard St., 6th Floor
Course Director: Bruce Gilliam, MD
Coordinator: Danielle Confer
Target Audience: Physicians, Resident/Fellows, Nurses, Physicians Assistant
Credits Offered: AMA PRA Category 1 Credits™ - 1.50; Attendance - 1.50
Date
Event
 
Registration
Tuesday-11/17/15
5:30 PM - 7:30 PM
 
IHV Case Conference Series 2015
New12106
Objective: At the conclusion of this activity, participants will be able to: 1. Treat and manage difficult cases in HIV 2. Manage a complex caseload 3. Define co-morbidities 4. Treat HCV and HIV 5. Describe the treatment cascade and how to achieve better outcomes along the continuum
725 West Lombard St., 6th Floor
Course Director: Bruce Gilliam, MD
Coordinator: Danielle Confer
Target Audience: Physicians, Resident/Fellows, Nurses, Physicians Assistant
Credits Offered: AMA PRA Category 1 Credits™ - 1.50; Attendance - 1.50
Date
Event
 
Registration
Wednesday-12/9/15
5:30 PM - 7:30 PM
 
IHV Case Conference Series 2015
New12107
Objective: At the conclusion of this activity, participants will be able to: 1. Treat and manage difficult cases in HIV 2. Manage a complex caseload 3. Define co-morbidities 4. Treat HCV and HIV 5. Describe the treatment cascade and how to achieve better outcomes along the continuum
725 West Lombard St., 6th Floor
Course Director: Bruce Gilliam, MD
Coordinator: Danielle Confer
Target Audience: Physicians, Resident/Fellows, Nurses, Physicians Assistant
Credits Offered: AMA PRA Category 1 Credits™ - 1.50; Attendance - 1.50